BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22549877)

  • 21. Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) mice.
    Rao CV; Mohammed A; Janakiram NB; Li Q; Ritchie RL; Lightfoot S; Vibhudutta A; Steele VE
    Neoplasia; 2012 Sep; 14(9):778-87. PubMed ID: 23019409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele.
    Wu J; Liu X; Nayak SG; Pitarresi JR; Cuitiño MC; Yu L; Hildreth BE; Thies KA; Schilling DJ; Fernandez SA; Leone G; Ostrowski MC
    PLoS One; 2017; 12(9):e0184984. PubMed ID: 28934293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis.
    Ge W; Goga A; He Y; Silva PN; Hirt CK; Herrmanns K; Guccini I; Godbersen S; Schwank G; Stoffel M
    Gastroenterology; 2022 Jan; 162(1):269-284. PubMed ID: 34547282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo.
    Qiu W; Sahin F; Iacobuzio-Donahue CA; Garcia-Carracedo D; Wang WM; Kuo CY; Chen D; Arking DE; Lowy AM; Hruban RH; Remotti HE; Su GH
    Oncotarget; 2011 Nov; 2(11):862-73. PubMed ID: 22113502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overall survival of pancreatic ductal adenocarcinoma is doubled by
    Lee JS; Lee H; Woo SM; Jang H; Jeon Y; Kim HY; Song J; Lee WJ; Hong EK; Park SJ; Han SS; Kim SY
    Theranostics; 2021; 11(7):3472-3488. PubMed ID: 33537098
    [No Abstract]   [Full Text] [Related]  

  • 26. Oxidative stress induced by inactivation of TP53INP1 cooperates with KrasG12D to initiate and promote pancreatic carcinogenesis in the murine pancreas.
    Al Saati T; Clerc P; Hanoun N; Peuget S; Lulka H; Gigoux V; Capilla F; Béluchon B; Couvelard A; Selves J; Buscail L; Carrier A; Dusetti N; Dufresne M
    Am J Pathol; 2013 Jun; 182(6):1996-2004. PubMed ID: 23578383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged survival and delayed progression of pancreatic intraepithelial neoplasia in LSL-KrasG12D/+;Pdx-1-Cre mice by vitamin E δ-tocotrienol.
    Husain K; Centeno BA; Chen DT; Fulp WJ; Perez M; Zhang Lee G; Luetteke N; Hingorani SR; Sebti SM; Malafa MP
    Carcinogenesis; 2013 Apr; 34(4):858-63. PubMed ID: 23302291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D
    DelGiorno KE; Chung CY; Vavinskaya V; Maurer HC; Novak SW; Lytle NK; Ma Z; Giraddi RR; Wang D; Fang L; Naeem RF; Andrade LR; Ali WH; Tseng H; Tsui C; Gubbala VB; Ridinger-Saison M; Ohmoto M; Erikson GA; O'Connor C; Shokhirev MN; Hah N; Urade Y; Matsumoto I; Kaech SM; Singh PK; Manor U; Olive KP; Wahl GM
    Gastroenterology; 2020 Nov; 159(5):1866-1881.e8. PubMed ID: 32717220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation.
    Dumartin L; Alrawashdeh W; Trabulo SM; Radon TP; Steiger K; Feakins RM; di Magliano MP; Heeschen C; Esposito I; Lemoine NR; Crnogorac-Jurcevic T
    Oncogene; 2017 Jun; 36(22):3094-3103. PubMed ID: 27941872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteasome activity is required for the initiation of precancerous pancreatic lesions.
    Furuyama T; Tanaka S; Shimada S; Akiyama Y; Matsumura S; Mitsunori Y; Aihara A; Ban D; Ochiai T; Kudo A; Fukamachi H; Arii S; Kawaguchi Y; Tanabe M
    Sci Rep; 2016 May; 6():27044. PubMed ID: 27244456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer.
    Pasquale V; Dugnani E; Liberati D; Marra P; Citro A; Canu T; Policardi M; Valla L; Esposito A; Piemonti L
    Acta Diabetol; 2019 Sep; 56(9):1013-1022. PubMed ID: 30989379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
    Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
    Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
    Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H
    Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of Brca2 cooperates with Trp53(R172H) to induce invasive pancreatic ductal adenocarcinomas in mice: a mouse model of familial pancreatic cancer.
    Feldmann G; Karikari C; dal Molin M; Duringer S; Volkmann P; Bartsch DK; Bisht S; Koorstra JB; Brossart P; Maitra A; Fendrich V
    Cancer Biol Ther; 2011 Jun; 11(11):959-68. PubMed ID: 21455033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
    Zhang S; Chung WC; Xu K
    Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.
    Vincent DF; Yan KP; Treilleux I; Gay F; Arfi V; Kaniewski B; Marie JC; Lepinasse F; Martel S; Goddard-Leon S; Iovanna JL; Dubus P; Garcia S; Puisieux A; Rimokh R; Bardeesy N; Scoazec JY; Losson R; Bartholin L
    PLoS Genet; 2009 Jul; 5(7):e1000575. PubMed ID: 19629168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis.
    Matsuura T; Maru Y; Izumiya M; Hoshi D; Kato S; Ochiai M; Hori M; Yamamoto S; Tatsuno K; Imai T; Aburatani H; Nakajima A; Hippo Y
    Carcinogenesis; 2020 Jun; 41(4):490-501. PubMed ID: 31233118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model.
    Chang HH; Moro A; Chou CEN; Dawson DW; French S; Schmidt AI; Sinnett-Smith J; Hao F; Hines OJ; Eibl G; Rozengurt E
    Sci Rep; 2018 Apr; 8(1):5899. PubMed ID: 29651002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The conditional expression of KRAS G12D in mouse pancreas induces disorganization of endocrine islets prior the onset of ductal pre-cancerous lesions.
    Gout J; Pommier RM; Vincent DF; Ripoche D; Goddard-Léon S; Colombe A; Treilleux I; Valcourt U; Tomasini R; Dufresne M; Bertolino P; Bartholin L
    Pancreatology; 2013; 13(3):191-5. PubMed ID: 23719586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer.
    DiNorcia J; Lee MK; Moroziewicz DN; Winner M; Suman P; Bao F; Remotti HE; Zou YS; Yan SF; Qiu W; Su GH; Schmidt AM; Allendorf JD
    J Gastrointest Surg; 2012 Jan; 16(1):104-12; discussion 112. PubMed ID: 22052106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.